5-hydroxymethylcytosine has been researched along with fulvestrant in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Balasubramanian, S; Broome, R; Carroll, JS; Chernukhin, I; D'Santos, C; Farcas, AM; Groen, AJ; Jamieson, S; Kishore, K; Mahtey, A; Mao, SQ; Papachristou, EK; Siersbæk, R; Tejedo, CG; Theodorou, V | 1 |
1 other study(ies) available for 5-hydroxymethylcytosine and fulvestrant
Article | Year |
---|---|
TET2 is a component of the estrogen receptor complex and controls 5mC to 5hmC conversion at estrogen receptor cis-regulatory regions.
Topics: 5-Methylcytosine; Animals; Breast Neoplasms; Chromatin Assembly and Disassembly; Databases, Genetic; Dioxygenases; DNA Methylation; DNA-Binding Proteins; Enhancer Elements, Genetic; Estrogen Receptor alpha; Estrogen Receptor Antagonists; Female; Fulvestrant; GATA3 Transcription Factor; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Mice, Inbred NOD; Mice, SCID; Xenograft Model Antitumor Assays | 2021 |